000 01229 a2200289 4500
005 20250518045739.0
264 0 _c20200724
008 202007s 0 0 eng d
022 _a2210-741X
024 7 _a10.1016/j.clinre.2019.06.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLemoinne, Sara
245 0 0 _aGut microbiota in PSCĀ : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019.
_h[electronic resource]
260 _bClinics and research in hepatology and gastroenterology
_c04 2020
300 _a123-125 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aCholangitis, Sclerosing
650 0 4 _aEnterococcus
650 0 4 _aGastrointestinal Microbiome
650 0 4 _aHumans
650 0 4 _aLiver
650 0 4 _aTh17 Cells
700 1 _aSabino, Joao
700 1 _aSokol, Harry
773 0 _tClinics and research in hepatology and gastroenterology
_gvol. 44
_gno. 2
_gp. 123-125
856 4 0 _uhttps://doi.org/10.1016/j.clinre.2019.06.005
_zAvailable from publisher's website
999 _c29858938
_d29858938